|
Market Closed -
London S.E.
11:35:17 2026-09-24 EDT
|
5-day change | 1st Jan Change | ||
| 0.1700 GBX | -2.86% |
|
-8.11% | -15.00% |
| 08-20 | Theracryf's fund raise; Potter & Moore sales struggle | AN |
| 05-14 | EARNINGS & TRADING: Nexus Infrastructure first-half loss narrows | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| THERACRYF PLC | Bio Therapeutic Drugs | -2.86% | -8.11% | -15.00% | -29.17% | -97.14% | 6.34M |  | | |
- Stock Market
- Stocks
- EVG Stock
- Charts Theracryf Plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
